Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
While Medicare dental coverage remains extremely limited, the 2023 and 2024 Medicare Physician Fee Schedule (PFS) final rules expand access
Medicare’s annual Fall Open Enrollment (FOE) period runs from October 15 to December 7. It is the time of year
Younger adults can qualify for Medicare due to having a long-term disability, End-Stage Renal Disease (ESRD), or Amyotrophic Lateral Sclerosis
On October 18, the Senate Finance Committee held a hearing on Medicare Advantage (MA) marketing practices, with a focus on
Last month, two congressional committees debated policy changes at the intersection of Medicare rules and federal tax law, though the
Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,
Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open
A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
Many of Medicare’s 65 million enrollees can struggle to pay for coverage and care. The program’s benefit design and lack
While Medicare dental coverage remains extremely limited, the 2023 and 2024 Medicare Physician Fee Schedule (PFS) final rules expand access
Medicare’s annual Fall Open Enrollment (FOE) period runs from October 15 to December 7. It is the time of year
Younger adults can qualify for Medicare due to having a long-term disability, End-Stage Renal Disease (ESRD), or Amyotrophic Lateral Sclerosis
On October 18, the Senate Finance Committee held a hearing on Medicare Advantage (MA) marketing practices, with a focus on
Last month, two congressional committees debated policy changes at the intersection of Medicare rules and federal tax law, though the
Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,
Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open
A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
Many of Medicare’s 65 million enrollees can struggle to pay for coverage and care. The program’s benefit design and lack
